Gynecomastia natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
 
(31 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Gynecomastia}}
{{Gynecomastia}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{HS}}


==Overview==
==Overview==
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
If left untreated patients with gynecomastia may progress to develop [[Psychological stress|psychosocial stresses]] and rarely [[breast cancer]]. The majority of [[physiological]] gynecomastia is self-limited. [[Pathological]] gynecomastia has an excellent [[prognosis]] and responds well to treatment. [[Pharmacological]] [[gynecomastia]] responds very well to the cessation of the offending agent.
*Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
 
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==


===Natural History===
===Natural History===
* The signs of gynecomastia usually develops in neonatal, in pubertal age or in elderly.
* The signs and symptoms of [[gynecomastia]] typically develop in [[neonatal]], [[pubertal]] age or in the [[elderly]].<ref name="pmid8421478">{{cite journal| author=Braunstein GD| title=Gynecomastia. | journal=N Engl J Med | year= 1993 | volume= 328 | issue= 7 | pages= 490-5 | pmid=8421478 | doi=10.1056/NEJM199302183280708 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8421478  }} </ref><ref name="pmid2137877">{{cite journal |vauthors=Biro FM, Lucky AW, Huster GA, Morrison JA |title=Hormonal studies and physical maturation in adolescent gynecomastia |journal=J. Pediatr. |volume=116 |issue=3 |pages=450–5 |year=1990 |pmid=2137877 |doi= |url=}}</ref><ref name="pmid24872741">{{cite journal| author=Lemaine V, Cayci C, Simmons PS, Petty P| title=Gynecomastia in adolescent males. | journal=Semin Plast Surg | year= 2013 | volume= 27 | issue= 1 | pages= 56-61 | pmid=24872741 | doi=10.1055/s-0033-1347166 | pmc=3706045 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24872741  }} </ref>
 
* Without treatment [[gynecomastia]] has some associated risk of [[breast cancer]], however, the majority of [[physiological]] [[gynecomastia]] resolves in months to years.
* Without treatment gynecomastia has some associated risk of breast cancer, however, the majority of physiological gynecomastia resolves in months to years time.
 
* Secondary gynecomastia usually responds to treatment or removal of the underlying cause.


===Complications===
===Complications===
*Complications of gynecomastia include:
Complications of [[gynecomastia]] include:<ref name="pmidorg/10.1016/j.amjmed.2016.01.009">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=org/10.1016/j.amjmed.2016.01.009 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref><ref name="pmid26408934">{{cite journal| author=Ordaz DL, Thompson JK| title=Gynecomastia and psychological functioning: A review of the literature. | journal=Body Image | year= 2015 | volume= 15 | issue=  | pages= 141-8 | pmid=26408934 | doi=10.1016/j.bodyim.2015.08.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26408934  }} </ref><ref name="pmid26151806">{{cite journal| author=Rew L, Young C, Harrison T, Caridi R| title=A systematic review of literature on psychosocial aspects of gynecomastia in adolescents and young men. | journal=J Adolesc | year= 2015 | volume= 43 | issue=  | pages= 206-12 | pmid=26151806 | doi=10.1016/j.adolescence.2015.06.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26151806  }} </ref>
**Persistent pubertal gynecomastia
* Persistent [[pubertal]] gynecomastia
**Breast cancer
*[[Breast cancer]]
**Psychological stressess
*[[Psychological stress]] like:
**[[depression]]
**Reduced [[self-esteem]]
**Body dissatisfaction


===Prognosis===
===Prognosis===
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Gynecomastia prognosis is good overall:<ref>{{cite web | url = http://www.annalsplasticsurgery.com/pt/re/annps/abstract.00000637-200408000-00001.htm;jsessionid=F9bRttLWlcgHnBWVVgG3xcHwF1KbpJTPbgyLjKvQJXG977J7s1pP!1570379021!-949856144!8091!-1  | title = ''Gynecomastia: An Outcome Analysis'' | author = Wiesman, IM. et al.}}</ref><ref name="pmid21712702">{{cite journal| author=Li CC, Fu JP, Chang SC, Chen TM, Chen SG| title=Surgical treatment of gynecomastia: complications and outcomes. | journal=Ann Plast Surg | year= 2012 | volume= 69 | issue= 5 | pages= 510-5 | pmid=21712702 | doi=10.1097/SAP.0b013e318222834d | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21712702  }} </ref><ref name="pmid28451801">{{cite journal| author=Choi BS, Lee SR, Byun GY, Hwang SB, Koo BH| title=The Characteristics and Short-Term Surgical Outcomes of Adolescent Gynecomastia. | journal=Aesthetic Plast Surg | year= 2017 | volume=  | issue= | pages=  | pmid=28451801 | doi=10.1007/s00266-017-0886-z | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28451801  }} </ref>
*Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
* Physiological gynecomastia has an excellent [[prognosis]] and the majority of [[physiological]] gynecomastia resolve spontaneously.
*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
* Pathological gynecomastia also responds well to treatment or removal of the underlying cause.
*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
* [[Pharmacological]] gynecomastia responds very well to the cessation of the offending agent.
*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
* Persistent gynecomastia can cause [[psychological stress]] and increases the risk of [[breast cancer]].
 
Gynecomastia is not physically harmful, but in some cases can be an indicator of other more dangerous underlying conditions. Growing glandular tissue, typically from some form of hormonal stimulation, is often tender or painful. Furthermore, it can frequently present social and psychological difficulties for the sufferer.<ref>{{cite web | url = http://www.annalsplasticsurgery.com/pt/re/annps/abstract.00000637-200408000-00001.htm;jsessionid=F9bRttLWlcgHnBWVVgG3xcHwF1KbpJTPbgyLjKvQJXG977J7s1pP!1570379021!-949856144!8091!-1  | title = ''Gynecomastia: An Outcome Analysis'' | author = Wiesman, IM. et al.}}</ref> Weight loss can alter the condition in cases where it is triggered by obesity, but losing weight will not reduce the glandular component and patients cannot target areas for weight lossMassive weight loss can result in sagging tissues about the chest, chest [[ptosis (breasts)|ptosis]], or drooping chest.


==References==
==References==

Latest revision as of 23:29, 15 November 2017

Gynecomastia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gynecomastia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gynecomastia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gynecomastia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gynecomastia natural history, complications and prognosis

CDC on Gynecomastia natural history, complications and prognosis

Gynecomastia natural history, complications and prognosis in the news

Blogs on Gynecomastia natural history, complications and prognosis

Directions to Hospitals Treating Gynecomastia

Risk calculators and risk factors for Gynecomastia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

If left untreated patients with gynecomastia may progress to develop psychosocial stresses and rarely breast cancer. The majority of physiological gynecomastia is self-limited. Pathological gynecomastia has an excellent prognosis and responds well to treatment. Pharmacological gynecomastia responds very well to the cessation of the offending agent.

Natural History, Complications, and Prognosis

Natural History

Complications

Complications of gynecomastia include:[4][5][6]

Prognosis

Gynecomastia prognosis is good overall:[7][8][9]

  • Physiological gynecomastia has an excellent prognosis and the majority of physiological gynecomastia resolve spontaneously.
  • Pathological gynecomastia also responds well to treatment or removal of the underlying cause.
  • Pharmacological gynecomastia responds very well to the cessation of the offending agent.
  • Persistent gynecomastia can cause psychological stress and increases the risk of breast cancer.

References

  1. Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.
  2. Biro FM, Lucky AW, Huster GA, Morrison JA (1990). "Hormonal studies and physical maturation in adolescent gynecomastia". J. Pediatr. 116 (3): 450–5. PMID 2137877.
  3. Lemaine V, Cayci C, Simmons PS, Petty P (2013). "Gynecomastia in adolescent males". Semin Plast Surg. 27 (1): 56–61. doi:10.1055/s-0033-1347166. PMC 3706045. PMID 24872741.
  4. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID org/10.1016/j.amjmed.2016.01.009 Check |pmid= value (help).
  5. Ordaz DL, Thompson JK (2015). "Gynecomastia and psychological functioning: A review of the literature". Body Image. 15: 141–8. doi:10.1016/j.bodyim.2015.08.004. PMID 26408934.
  6. Rew L, Young C, Harrison T, Caridi R (2015). "A systematic review of literature on psychosocial aspects of gynecomastia in adolescents and young men". J Adolesc. 43: 206–12. doi:10.1016/j.adolescence.2015.06.007. PMID 26151806.
  7. Wiesman, IM.; et al. "Gynecomastia: An Outcome Analysis".
  8. Li CC, Fu JP, Chang SC, Chen TM, Chen SG (2012). "Surgical treatment of gynecomastia: complications and outcomes". Ann Plast Surg. 69 (5): 510–5. doi:10.1097/SAP.0b013e318222834d. PMID 21712702.
  9. Choi BS, Lee SR, Byun GY, Hwang SB, Koo BH (2017). "The Characteristics and Short-Term Surgical Outcomes of Adolescent Gynecomastia". Aesthetic Plast Surg. doi:10.1007/s00266-017-0886-z. PMID 28451801.

Template:WH Template:WS